Next Article in Journal
Lactoferrin from Milk: Nutraceutical and Pharmacological Properties
Next Article in Special Issue
pMPES: A Modular Peptide Expression System for the Delivery of Antimicrobial Peptides to the Site of Gastrointestinal Infections Using Probiotics
Previous Article in Journal
TRPV3 in Drug Development
Previous Article in Special Issue
Therapeutic Potential of Gramicidin S in the Treatment of Root Canal Infections
Open AccessReview

Antimicrobial Peptides Targeting Gram-Positive Bacteria

Institute of Molecular Biosciences, Biophysics Division, University of Graz, NAWI Graz, Humboldtstrasse 50/III, 8010 Graz, Austria
BioTechMed Graz, Humboldtstrasse 50/III, 8010 Graz, Austria
Author to whom correspondence should be addressed.
Academic Editor: Guangshun Wang
Pharmaceuticals 2016, 9(3), 59;
Received: 22 July 2016 / Revised: 7 September 2016 / Accepted: 13 September 2016 / Published: 20 September 2016
(This article belongs to the Special Issue Antimicrobial Peptides: Expanded Activity Spectrum and Applications)
Antimicrobial peptides (AMPs) have remarkably different structures as well as biological activity profiles, whereupon most of these peptides are supposed to kill bacteria via membrane damage. In order to understand their molecular mechanism and target cell specificity for Gram-positive bacteria, it is essential to consider the architecture of their cell envelopes. Before AMPs can interact with the cytoplasmic membrane of Gram-positive bacteria, they have to traverse the cell wall composed of wall- and lipoteichoic acids and peptidoglycan. While interaction of AMPs with peptidoglycan might rather facilitate penetration, interaction with anionic teichoic acids may act as either a trap for AMPs or a ladder for a route to the cytoplasmic membrane. Interaction with the cytoplasmic membrane frequently leads to lipid segregation affecting membrane domain organization, which affects membrane permeability, inhibits cell division processes or leads to delocalization of essential peripheral membrane proteins. Further, precursors of cell wall components, especially the highly conserved lipid II, are directly targeted by AMPs. Thereby, the peptides do not inhibit peptidoglycan synthesis via binding to proteins like common antibiotics, but form a complex with the precursor molecule, which in addition can promote pore formation and membrane disruption. Thus, the multifaceted mode of actions will make AMPs superior to antibiotics that act only on one specific target. View Full-Text
Keywords: cell wall; lipoteichoic acid; peptidoglycan biosynthesis; membrane phospholipids; mode of action of AMPs cell wall; lipoteichoic acid; peptidoglycan biosynthesis; membrane phospholipids; mode of action of AMPs
Show Figures

Figure 1

MDPI and ACS Style

Malanovic, N.; Lohner, K. Antimicrobial Peptides Targeting Gram-Positive Bacteria. Pharmaceuticals 2016, 9, 59.

AMA Style

Malanovic N, Lohner K. Antimicrobial Peptides Targeting Gram-Positive Bacteria. Pharmaceuticals. 2016; 9(3):59.

Chicago/Turabian Style

Malanovic, Nermina; Lohner, Karl. 2016. "Antimicrobial Peptides Targeting Gram-Positive Bacteria" Pharmaceuticals 9, no. 3: 59.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop